Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We examined whether benefits and risks of intensified antihypertensive therapy in diabetes mellitus are influenced by either baseline BP or cardiovascular disease (CVD) risk. We studied 10 948 people with...
Հիմնական հեղինակներ: | Rahman, F, McEvoy, J, Ohkuma, T, Marre, M, Hamet, P, Harrap, S, Mancia, G, Rodgers, A, Selvin, E, Williams, B, Muntner, P, Chalmers, J, Woodward, M |
---|---|
Ձևաչափ: | Journal article |
Հրապարակվել է: |
American Heart Association
2019
|
Նմանատիպ նյութեր
-
Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
: Atkins, A, և այլն
Հրապարակվել է: (2017) -
Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
: Selvin, E, և այլն
Հրապարակվել է: (2019) -
Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
: Ohkuma, T, և այլն
Հրապարակվել է: (2017) -
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
: Czernichow, S, և այլն
Հրապարակվել է: (2011) -
Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
: Kengne, A, և այլն
Հրապարակվել է: (2009)